Key result
Higher pulse pressure linked to ~94% greater CKD risk per SD in type 2 diabetes.
Why the study?
Identification of factors associated with risk of progression of chronic kidney disease may help in earlier intervention in high-risk groups, including those with type 2 diabetes.
Does higher brachial pulse pressure increase the risk of eGFR decline and incident CKD in individuals with and without type 2 diabetes?
Cohort (n=5,554)
Does higher brachial pulse pressure increase the risk of eGFR decline and incident CKD in individuals with and without type 2 diabetes?
Higher pulse pressure is a significant risk factor for eGFR decline and incident CKD over 5 years, with the risk being substantially amplified in patients with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
Pulse pressure may flag elevated CKD risk in diabetes; leaves open whether targeting it alters progression.
OBJECTIVE: Chronic kidney disease (CKD) is a serious disorder with significant public health impact. Identification of factors associated with risk of progression of kidney disease may help in earlier intervention in high-risk groups. We investigated whether brachial pulse pressure (PP) was associated with 5-year changes in estimated glomerular filtration rate (eGFR) and incident CKD and whether type 2 diabetes modified these associations. METHODS: In the population-based Australian Diabetes, Obesity and Lifestyle Study (AusDiab) 5554 individuals (5.8% with type 2 diabetes) who took part in the 5-year follow-up and had no CKD or microalbuminuria at baseline were included. RESULTS: After adjusting for baseline age, sex, eGFR and use of blood pressure-lowering medication, each baseline SD higher PP was associated with a decline in eGFR of 0.32 ml/min (P=0.006) and an odds ratio (OR) for CKD of 1.29 [95% confidence interval (CI) 1.09-1.53] in individuals without type 2 diabetes. In individuals with type 2 diabetes, eGFR declined by 1.10 ml/min (P=0.011) and the OR for incident CKD was 1.94 (1.14-3.29). Similar associations with eGFR decline were observed with systolic blood pressure and incident CKD in individuals without type 2 diabetes. In individuals with type 2 diabetes, higher systolic blood pressure was only significantly associated with eGFR decline if the diastolic blood pressure was 70 mmHg or less (P for interaction between systolic and diastolic blood pressure: 0.033). CONCLUSIONS: PP is an important risk factor for eGFR decline and incident CKD over a 5-year period, especially in individuals with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Hurk et al. (2011) conducted a cohort in Chronic kidney disease (n=5,554). Higher brachial pulse pressure vs. Lower brachial pulse pressure was evaluated on Incident CKD (OR 1.94, 95% CI 1.14-3.29). Each standard deviation increase in baseline pulse pressure was associated with incident chronic kidney disease over 5 years, with a stronger effect in type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: